Skip to content
Screener

Glaukos GKOS Q2 2026 earnings

Reported July 29, 2026 · After market close

Revenue$185.6MBeat by $34.7M
EPS-$0.14Beat by $0.07
Revenue estimate$150.9M
EPS estimate-$0.21
“We continue to successfully advance our robust pipeline of novel, dropless platform technologies designed to meaningfully advance the standard of care and improve outcomes for patients suffering from chronic eye diseases.”
Thomas Burns

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$167.9M
EPS estimate-$0.12

Financials

Q2 2026

Income statement

See full
Revenue$185.6M+49.5%
Gross profit$151.6M+55.9%
Operating income-$17.3M+23.9%
Net income-$18.4M+6.5%
EPS (diluted)-$0.31+8.8%

Balance sheet

See full
Cash & equivalents$114.5M+13.6%
Total debt$105.9M-1.4%
Total equity$682.5M-10.8%
Total assets$920.5M-6.7%

Cash flow

See full
Operating cash flow$14.8M—
CapEx$2.7M+132%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$9.64B+105%
Enterprise value$9.63B+104%
P/S15.7×+4.9×

Profitability

See full
Gross margin61%-15.4pp
Operating margin-31.6%+22.2pp
Net margin-30.7%+23.3pp

Returns & leverage

See full
Return on equity-26%-11,301pp
Debt / equity0.2×0.0×
Current ratio5×-0.5×

Segments

By product

See full
Glaucoma$155.2M+49.9%
Corneal Health$30.4M+47.8%

By segment

See full
Development And Commercialization Of Ophthalmic Therapies$185.6M+49.5%

By geography

See full
US$146.7M—

FAQ

When did Glaukos report Q2 2026 earnings?
Glaukos (GKOS) reported Q2 2026 earnings on July 29, 2026 after market close.
What were Glaukos's Q2 2026 revenue and EPS?
Glaukos reported revenue of $185.6M and eps of $-0.14 for Q2 2026.
Did Glaukos beat estimates in Q2 2026?
Revenue beat the consensus estimate of $150.9M by $34.7M. EPS beat the consensus estimate of $-0.21 by $0.07.
How did Glaukos's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 49.5% from $124.1M a year earlier and eps grew 41.7% from $-0.24.
Where can I find Glaukos's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-323729) and the 10-Q periodic report (0001193125-26-324201) directly on SEC EDGAR. The filing index links above go to sec.gov.